Vaibhav Sahai, MBBS, MS
University of Michigan · University of Michigan Rogel Cancer Center · Rogel Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Vaibhav Sahai, MBBS, MS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07723534 · Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract CancersMidhun Malla · not yet recruiting · Advanced Biliary Tract Cancer, Metastatic Biliary Tract Carcinoma · principal investigator
- Ph1/Ph2NCT04497038 · Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line TherapyUniversity of Michigan Rogel Cancer Center · terminated · Advanced Adult Hepatocellular Carcinoma · principal investigator
- Ph1/Ph2NCT04203160 · Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)University of Michigan Rogel Cancer Center · terminated · Biliary Tract Cancer · principal investigator
- Ph1/Ph2NCT03785873 · Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract CancerUniversity of Michigan Rogel Cancer Center · completed · Biliary Tract Cancer · principal investigator
- Ph2NCT03639935 · Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum TherapyUniversity of Michigan Rogel Cancer Center · completed · Biliary Tract Cancer · principal investigator
- Ph2NCT03101566 · Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract CancerUniversity of Michigan Rogel Cancer Center · completed · Biliary Tract Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.